Merrill M. Kraines is a partner in the Health Sciences Department of Pepper Hamilton LLP, resident in the New York office. Mr. Kraines is primarily engaged in corporate, securities and mergers and acquisitions matters. He leads the life sciences, technology and emerging growth practices in New York. Mr. Kraines represents many life sciences companies, including biotechnology, therapeutic, diagnostic and medical device companies. He has also represented or been involved in transactions concerning a variety of other growth companies in all phases of business and finance in many industries, including: software, Internet, health care, IT, alternative energy, financial services, IT consulting, educational publishing, entertainment, office products, advertising, telecommunications, paper and many other companies. These companies have ranged from start-ups to large public concerns.
Mr. Kraines also represents investment banking firms in connection with public offerings, private placements, sale advisory transactions, fairness opinions and other matters. He has handled numerous initial and secondary public offerings, private placements, PIPE transactions, 144A transactions, mergers and acquisitions, licensing and distribution arrangements, joint ventures and cross-border transactions. Mr. Kraines also represents numerous private equity and venture capital firms, both independent and those associated with commercial banks, corporations, universities and medical centers in their fund formation, investment and restructuring activities.
Mr. Kraines advises public companies on matters of corporate governance, securities filings, NYSE and NASDAQ compliance, Sarbanes-Oxley compliance, government investigations and the like. Mr. Kraines has served as a director and officer of several public companies.
Prior to joining Pepper, Mr. Kraines was a partner with Norton Rose Fulbright in New York.